Charles Burger, MD: Pulmonary hypertension really refers to a state where the right heart is generating high pressures to circulate the blood through the lung. Pulmonary arterial hypertension is a ...

Frailty and accelerated aging are common in pulmonary hypertension, with frailty an independent risk factor for early death.

The use of anticoagulants is not associated with improved overall survival in patients with pulmonary arterial hypertension, ...

Sotatercept (Winrevair) represents the first new mechanism of action for pulmonary arterial hypertension (PAH) treatment in over a decade, offering hope for patients with this life-threatening ...

Please provide your email address to receive an email when new articles are posted on . Hospitalizations for pulmonary hypertension have increased from 1980 to 2002, resulting in 200,000 ...

—Levels of certain hormones in both men and postmenopausal women have been associated with an increased incidence of pulmonary arterial hypertension (PAH). A new study reveals a bit more. Reviewed by ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. This is something I'm particularly ...

A new study published in The New England Journal of Medicine showed that within a year after being diagnosed with pulmonary ...

Pulmonary Circulation, Vol. 5, No. 1 (March 2015), pp. 204-210 (7 pages) AbstractPeripheral pulmonary artery stenosis (PPAS) is an underrecognized condition in the adult population. PPAS can lead to ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (NASDAQ:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta therapeutics to treat serious and rare diseases ...

Pulmonary hypertension is traditionally defined as a mean pulmonary artery pressure of ≥25 mmHg when a patient is at rest, though a mean pressure of >20 mm Hg is considered to be abnormal and may ...